Abbott Laboratories Receives FDA Approval For HeartMate 3 LVAD System

Abbott Laboratories Receives FDA Approval For HeartMate 3 LVAD System

Abbott Laboratories received U.S. Food and Drug Administration approval for its full MagLev HeartMate 3 Left Ventricular Assist System (LVAD). The HeartMate 3 system provides advanced heart failure patients in need of short-term hemodynamic support and improved blood flow in a pump that uses full magnetic levitation to reduce trauma to blood passing through the LVAD system. The decision by the FDA was supported by the Momentum 3 clinical study […]

Read More ˃